Original paper
Late-breaking abstract: Oral corticosteroid-sparing effect of mepolizumab in severe eosinophilic asthma: The SIRIUS study
Volume: 44, Pages: 2907
Published: Sep 1, 2014
Abstract
Background: null There is an unmet treatment need in a sub-population of severe asthma patients who, despite the use of maximal inhaled therapy, require regular treatment with oral corticosteroids (OCS). null null Objective: null To study the steroid-sparing effect of mepolizumab in severe eosinophilic asthma. null null Methods: null We conducted a randomized, double-blind placebo controlled trial of mepolizumab (n=69) administered as monthly...
Paper Details
Title
Late-breaking abstract: Oral corticosteroid-sparing effect of mepolizumab in severe eosinophilic asthma: The SIRIUS study
Published Date
Sep 1, 2014
Volume
44
Pages
2907
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History